How are Interleukins Targeted in Pediatric Therapies?
Targeting interleukins has become a promising strategy in treating pediatric diseases. Biologic therapies that inhibit specific interleukins, such as IL-1 and IL-6 inhibitors, have been developed to treat conditions like systemic juvenile idiopathic arthritis. These treatments can significantly reduce inflammation and improve patient outcomes.
